Skadden, Arps, Slate, Meagher & Flom LLP

Skadden, Arps, Slate, Meagher & Flom LLP advises life sciences clients on major M&A, with notable strength in acquisitions and dispositions, corporate restructurings, and joint ventures. The firm also handles litigation related to Medicaid, Medicare and insurance fraud, the False Claims Act,  mass torts, and securities, as well as Congressional investigations under the Foreign Corrupt Practices Act. On the regulatory side, it provides FDA regulatory diligence in connection with acquisitions, divestitures, financing, and investments, along with guidance on compliance and corporate governance. Also in Boston, Laura Knoll focuses on M&A and general corporate matters, including shareholder activism defense and securities compliance. Graham Robinson has left the firm.